# ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

> **NCT02252380** · NA · ACTIVE_NOT_RECRUITING · sponsor: **InSightec** · enrollment: 10 (estimated)

## Conditions studied

- Movement Disorders
- Essential Tremor
- Holmes Tremor
- Parkinson's Disease
- Wilson's Disease
- Huntington's Disease
- Dystonia
- Tardive Dyskinesia
- Orofacial Dyskinesias

## Interventions

- **DEVICE:** Transcranial ExAblate System

## Key facts

- **NCT ID:** NCT02252380
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-05
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252380, "ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02252380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*